• Clodronate Liposomes: Transforming In Vivo Macrophage Deplet

  2026-05-14

  Clodronate Liposomes enable precise, reproducible in vivo macrophage depletion, advancing functional immunology research. This article explores their mechanism, protocol nuances, and critical insights from recent single-cell studies that reshape experimental design.

• BAF53a Drives Glioma Progression and EMT: Prognostic Implica

  2026-05-14

  Meng et al. identify BAF53a as a novel independent prognostic biomarker in glioma, mechanistically linking its overexpression to enhanced proliferation, invasion, and epithelial-mesenchymal transition (EMT) in glioma cells. These findings deepen our understanding of glioma aggressiveness and suggest BAF53a as a potential therapeutic target.

• Therapy Sequencing in Waldenström Macroglobulinemia: CXCR4’s

  2026-05-13

  This article analyzes recent evidence guiding therapy sequencing in Waldenström macroglobulinemia (WM), with a focus on the clinical impact of MYD88 and CXCR4 mutations. The reference study highlights how genomic profiling—especially CXCR4 status—shapes regimen choices, and discusses the emergence of targeted antagonists such as mavorixafor in translational research.

• Cholecystokinin Octapeptide Ammonium: Applied Workflows & Tr

  2026-05-13

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) streamlines neurobehavioral, cell signaling, and immunological assays, providing robust, reproducible data across diverse models. This guide delivers actionable workflow optimizations, protocol parameters, and troubleshooting insights to unleash the full potential of CCK-8 ammonium in advanced research.

• Go 6983 in Neurobehavioral PKC Research: From ASD Models to

  2026-05-12

  Explore how Go 6983, a potent pan-PKC inhibitor, is redefining PKC signaling pathway research in neurobehavioral models, with a focus on translational insights for autism spectrum disorder (ASD). This article uncovers new mechanistic depth, bridging molecular findings to practical assay strategy.

• Plant Protein Secretion Protocols: Innovations and pH Measur

  2026-05-12

  The second edition of 'Plant Protein Secretion: Methods and Protocols' delivers detailed, reproducible methodologies for investigating both conventional and unconventional protein secretion in plant cells. Its rigorously validated protocols, including those for dynamic pH measurement, advance the precision and reproducibility of plant cell biology research.

• m6A RNA Modification in Plant-Virus Interactions: Antagonist

  2026-05-11

  This study uncovers a mutually antagonistic mechanism involving m6A RNA modification in the arms race between Arabidopsis and Cucumber mosaic virus (CMV). By elucidating how viral proteins manipulate host methyltransferases and m6A readers, the research provides new molecular insight into plant antiviral defense and viral countermeasures.

• Chlorpromazine HCl: Beyond Dopamine Antagonism in Host Immun

  2026-05-11

  Explore how Chlorpromazine HCl, a dopamine receptor antagonist, is redefining its role in neuropharmacology and host-directed antibacterial research. This article delivers in-depth scientific insights and unique protocol guidance for advanced assay design.

• Trelagliptin succinate: Optimized Workflows for Diabetes Res

  2026-05-10

  Trelagliptin succinate (SYR-472 succinate) empowers researchers with a robust, selective DPP-4 inhibition strategy for type 2 diabetes and comorbidity models. This guide translates recent experimental findings into actionable protocols, troubleshooting, and advanced applications to maximize reproducibility and biological insight.

• Puromycin Aminonucleoside: Applied Workflows in Podocyte Inj

  2026-05-09

  Puromycin aminonucleoside enables precise, reproducible induction of podocyte injury and proteinuria, making it indispensable for nephrotic syndrome research. This guide delivers stepwise experimental workflows, optimization strategies, and troubleshooting insights for maximizing translational relevance in glomerular lesion modeling.

• Applied Workflows with (-)-Epigallocatechin Gallate (EGCG)

  2026-05-08

  (-)-Epigallocatechin gallate (EGCG) stands out as a versatile bioactive for antiangiogenic, apoptosis, and antiviral research. This article details evidence-backed protocols, advanced assay applications, and optimization strategies that harness EGCG’s multifaceted potential—enabling reproducible, high-impact experimental outcomes.

• L-Ornithine in the Liver–Brain Axis: Mechanisms and Strategy

  2026-05-08

  Explore the latest mechanistic insights and translational strategies for leveraging L-Ornithine ((S)-2,5-diaminopentanoic acid) in research on ammonia detoxification, CNS-liver crosstalk, and metabolic enzyme dysfunction. Anchored by new evidence implicating ornithine accumulation in arsenic-induced neurotoxicity, this article provides actionable experimental guidance and a forward-looking vision for advancing metabolic and neurotoxicology research. Contextual product intelligence and rigorous evidence integration distinguish this discussion from standard reagent guides.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-05-07

  This study presents a nanoparticle platform for systemic delivery of PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN expression and inhibiting the PI3K/Akt pathway, this approach offers a mechanistically rational strategy for combating resistance in targeted cancer therapy.

• MLN4924: Precision NEDD8-Activating Enzyme Inhibitor in Canc

  2026-05-07

  MLN4924, a potent NEDD8-activating enzyme inhibitor, enables researchers to dissect neddylation-dependent processes with unparalleled specificity in cancer models. This guide details experimental workflows, troubleshooting strategies, and translational applications, bridging new mechanistic insights with robust, reproducible assay design.

• hiPSC-Derived Intestinal Organoids in Pharmacokinetic Studie

  2026-05-06

  This study presents a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) capable of differentiating into mature enterocytes with functional cytochrome P450 activity. The findings provide a more physiologically relevant in vitro platform for pharmacokinetic and drug metabolism research, overcoming key limitations of animal and cancer cell models.

14608 records 1/974 page Next 12345 下5页 Last page